SK280480B6 - N-alkyl-3-fenyl-3-(2-alkyltiofenoxy) propylamín, s - Google Patents

N-alkyl-3-fenyl-3-(2-alkyltiofenoxy) propylamín, s Download PDF

Info

Publication number
SK280480B6
SK280480B6 SK2908-92A SK290892A SK280480B6 SK 280480 B6 SK280480 B6 SK 280480B6 SK 290892 A SK290892 A SK 290892A SK 280480 B6 SK280480 B6 SK 280480B6
Authority
SK
Slovakia
Prior art keywords
phenyl
alkyl
alkylthiophenoxy
propylamine
formula
Prior art date
Application number
SK2908-92A
Other languages
English (en)
Slovak (sk)
Other versions
SK290892A3 (en
Inventor
Donald R. Gehlert
David W. Robertson
David T. Wong
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of SK280480B6 publication Critical patent/SK280480B6/sk
Publication of SK290892A3 publication Critical patent/SK290892A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/24—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/29—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/48—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C323/18—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C07C323/20—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton with singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Addiction (AREA)
  • Toxicology (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SK2908-92A 1991-09-27 1992-09-22 N-alkyl-3-phenyl-3-(2-alkylthiophenoxy)propylamine, a method of their preparation and pharmaceutical composition them containing SK290892A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/766,993 US5281624A (en) 1991-09-27 1991-09-27 N-alkyl-3-phenyl-3-(2-substituted phenoxy) propylamines and pharmaceutical use thereof

Publications (2)

Publication Number Publication Date
SK280480B6 true SK280480B6 (sk) 2000-02-14
SK290892A3 SK290892A3 (en) 2000-02-14

Family

ID=25078150

Family Applications (1)

Application Number Title Priority Date Filing Date
SK2908-92A SK290892A3 (en) 1991-09-27 1992-09-22 N-alkyl-3-phenyl-3-(2-alkylthiophenoxy)propylamine, a method of their preparation and pharmaceutical composition them containing

Country Status (23)

Country Link
US (1) US5281624A (es)
EP (1) EP0534756A3 (es)
JP (2) JP3256291B2 (es)
KR (1) KR100221180B1 (es)
CN (1) CN1033580C (es)
AT (1) ATE124934T1 (es)
AU (1) AU655075B2 (es)
BR (2) BR9203743A (es)
CA (2) CA2079161C (es)
CZ (1) CZ281817B6 (es)
DE (1) DE69203424T2 (es)
FI (1) FI111250B (es)
HU (1) HU215519B (es)
IL (1) IL103277A (es)
MX (1) MX9205433A (es)
MY (1) MY108304A (es)
NO (1) NO178109C (es)
NZ (1) NZ244460A (es)
RU (1) RU2057120C1 (es)
SK (1) SK290892A3 (es)
TW (1) TW249225B (es)
YU (1) YU87192A (es)
ZA (1) ZA927240B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6071970A (en) * 1993-02-08 2000-06-06 Nps Pharmaceuticals, Inc. Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
US6017965A (en) * 1993-02-08 2000-01-25 Nps Pharmaceuticals, Inc. Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
US7087765B2 (en) * 1995-06-07 2006-08-08 Nps Pharmaceuticals, Inc. Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
TW344661B (en) * 1993-11-24 1998-11-11 Lilly Co Eli Pharmaceutical composition for treatment of incontinence
JPH11510143A (ja) * 1995-07-24 1999-09-07 イーライ・リリー・アンド・カンパニー 注意不足／活動亢進障害の処置
KR20010029519A (ko) * 1996-09-19 2001-04-06 이곤 이 버그 요실금 치료 방법
AU756373B2 (en) * 1998-04-09 2003-01-09 Pharmacia & Upjohn Company New treatments for nervous disorders
US6586427B2 (en) 1998-04-09 2003-07-01 Pharmacia & Upjohn Company Treatments for nervous disorders
US6342533B1 (en) 1998-12-01 2002-01-29 Sepracor, Inc. Derivatives of (−)-venlafaxine and methods of preparing and using the same
WO2000059851A1 (en) * 1999-04-06 2000-10-12 Sepracor Inc. Derivatives of venlafaxine and methods of preparing and using the same
KR100882544B1 (ko) * 1999-05-24 2009-02-12 미쓰비시 타나베 파마 코퍼레이션 페녹시프로필아민 화합물
ES2242175T3 (es) * 1999-07-01 2005-11-01 PHARMACIA & UPJOHN COMPANY LLC (s,s)-reboxetina para tratar la fibromialgia y otros trastornos somatoformes.
US20040034106A1 (en) * 2001-11-06 2004-02-19 Read Holly Ann Treatment of anxiety disorders
EP1455770B1 (en) * 2001-11-30 2007-06-20 Eli Lilly And Company Use of norepinephrine reuptake inhibitors for the treatment of tic disorders
ES2295435T3 (es) * 2001-12-11 2008-04-16 Eli Lilly And Company Uso de inhibidores de la recaptacion de norepinefrina para el tratamiento del fallo cognitivo.
ATE365554T1 (de) * 2003-04-04 2007-07-15 Dynogen Pharmaceuticals Inc Methode zur behandlung von erkrankungen der unteren harnwege
WO2005020976A2 (en) * 2003-08-27 2005-03-10 Eli Lilly And Company Treatment of pervasive developmental disorders with norepinephrine reuptake inhibitors
CA2548304A1 (en) * 2003-12-12 2005-07-07 Eli Lilly And Company Selective norepinephrine reuptake inhibitors for the treatment of hot flashes, impulse control disorders and personality change due to a general medical condition
ITMI20061987A1 (it) 2006-10-16 2008-04-17 Archimica Srl Processo per la sintesi di arilossipropilammine ed eteroarilossipropilammine.
WO2019076904A1 (en) * 2017-10-16 2019-04-25 Esteve Pharmaceuticals, S.A. PROPANAMINE DERIVATIVES FOR THE TREATMENT OF PAIN AND PAIN DISEASES ASSOCIATED WITH PAIN
CN113121394B (zh) * 2019-12-30 2022-11-08 中国药科大学 一种苯氧乙酸类衍生物的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4018895A (en) * 1974-01-10 1977-04-19 Eli Lilly And Company Aryloxyphenylpropylamines in treating depression
US4584404A (en) * 1974-01-10 1986-04-22 Eli Lilly And Company Substituted phenoxyphenylproply dimethylamines
US4626549A (en) * 1974-01-10 1986-12-02 Eli Lilly And Company Treatment of obesity with aryloxyphenylpropylamines
US4313896A (en) * 1974-01-10 1982-02-02 Eli Lilly And Company Aryloxyphenylpropylamines
US4314081A (en) * 1974-01-10 1982-02-02 Eli Lilly And Company Arloxyphenylpropylamines
US4194009A (en) * 1974-01-10 1980-03-18 Eli Lilly And Company Aryloxyphenylpropylamines for obtaining a psychotropic effect
ZA892517B (en) * 1988-04-08 1990-12-28 Lilly Co Eli Propanamine derivatives

Also Published As

Publication number Publication date
BR9203743A (pt) 1993-04-20
HUT65375A (en) 1994-05-02
FI924305A (fi) 1993-03-28
IL103277A (en) 1997-11-20
IL103277A0 (en) 1993-02-21
TW249225B (es) 1995-06-11
CZ290892A3 (en) 1993-04-14
RU2057120C1 (ru) 1996-03-27
SK290892A3 (en) 2000-02-14
JPH05201961A (ja) 1993-08-10
US5281624A (en) 1994-01-25
FI111250B (fi) 2003-06-30
DE69203424T2 (de) 1996-01-11
YU87192A (sh) 1995-10-24
HU215519B (hu) 1999-01-28
KR930005972A (ko) 1993-04-20
CN1071416A (zh) 1993-04-28
ZA927240B (en) 1994-03-22
MX9205433A (es) 1993-03-01
JPH05238996A (ja) 1993-09-17
AU2537092A (en) 1993-04-01
NO178109B (no) 1995-10-16
MY108304A (en) 1996-09-30
CA2079162A1 (en) 1993-03-28
DE69203424D1 (de) 1995-08-17
HU9203051D0 (en) 1992-12-28
CA2079161A1 (en) 1993-03-28
NZ244460A (en) 1994-10-26
NO923710L (no) 1993-03-29
BR1100384A (pt) 1999-08-31
EP0534756A2 (en) 1993-03-31
CZ281817B6 (cs) 1997-02-12
JP3256291B2 (ja) 2002-02-12
ATE124934T1 (de) 1995-07-15
AU655075B2 (en) 1994-12-01
CN1033580C (zh) 1996-12-18
NO178109C (no) 1996-01-24
NO923710D0 (no) 1992-09-24
EP0534756A3 (en) 1993-06-16
KR100221180B1 (ko) 1999-09-15
FI924305A0 (fi) 1992-09-25
CA2079161C (en) 2004-02-17

Similar Documents

Publication Publication Date Title
SK280480B6 (sk) N-alkyl-3-fenyl-3-(2-alkyltiofenoxy) propylamín, s
FI77018C (fi) Analogifoerfarande foer framstaellning av antidepressivt aktiv (-)-enantiomer av n-metyl-n-/3-(2-metylfenoxi) -3-fenylpropyl/amin och dess farmaceutiskt godtagbara salt.
KR960003808B1 (ko) 3-아릴옥시-3-치환된 프로판아민, 이의 제조방법 및 이를 함유하는 약제학적 조성물
US4626549A (en) Treatment of obesity with aryloxyphenylpropylamines
CA1329937C (en) 1-phenyl-3-naphthalenyloxypropanamines
CA2071897A1 (en) Sigma receptor ligands and the use thereof
DK159146B (da) Analogifremgangsmaade til fremstilling af 1,2-diaminocyclobuten-3,4-dioner og cyclobuten-3,4-dionderivater til anvendelse som mellemprodukter i fremgangsmaaden
CA2002483C (en) Fluoxetine analog
RU2001911C1 (ru) Способ получени замещенных 1,2,3,4-тетрагидронафталинов или их фармацевтически приемлемых аддитивных солей кислоты
US5026707A (en) Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes
AU611794B2 (en) Improvements in or relating to propanamine derivatives
EP0537915B1 (en) N-alkyl-3-phenyl-3-(2-alkylthiophenoxy)propylamines as norepinephrine inhibitors
DE69828522T2 (de) Antithrombotische mittel
EP0591581B1 (en) N-Alkyl-3-phenyl-3-(2-alkylthiophenoxy)propylamines
US4876282A (en) 1-Phenylalkylamines as selective serotonin uptake inhibitors
JPS6011898B2 (ja) 新ベンゼンスルホンアミド誘導体、それらの製造法およびそれらを含有する医薬組成物
DE69630523T2 (de) Verwendung von Calciumkanalanantagonisten zur Behandlung von Herz-, Nieren-, Magen-und Darmkrankheiten sowie Bluthochdruck
CA1276153C (en) Therapeutically active, membrane stablizing compounds